Login to Your Account


2013 dealmaking hit $158B with a focus on early stage assets

By Michael Fitzhugh
Staff Writer

Wednesday, April 30, 2014
SAN FRANCISCO ­– Following 2013's strong dealmaking streak, the first quarter of 2014 is carrying its momentum, evidenced by 587 announced deals and $49.7 billion in total disclosed deal value, according to data released at Allicense 2014, in San Francisco.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription